James M. Thorburn - Nov 2, 2023 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role
Chief Financial Officer
Signature
/s/ Alyssa Zhang, as Attorney-in-Fact for James M. Thorburn
Stock symbol
TWST
Transactions as of
Nov 2, 2023
Transactions value $
-$72,079
Form type
4
Date filed
11/6/2023, 04:14 PM
Previous filing
Oct 26, 2023
Next filing
Nov 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TWST Common Stock Award $0 +19.8K +33.73% $0.00 78.4K Nov 2, 2023 Direct F1
transaction TWST Common Stock Tax liability -$72.1K -4.16K -5.31% $17.31 74.2K Nov 2, 2023 Direct F2
transaction TWST Common Stock Award $0 +14.1K +18.98% $0.00 88.3K Nov 2, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance stock units for which target criteria was determined to have been met on November 2, 2023. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2024, subject to continued service or acceleration of vesting as provided in the award agreement.
F2 Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
F3 Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 2, 2023 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date.